[Elsevier] Felzartamab plus lenalidomide每dexamethasone versus lenalidomide每dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial

Glivec Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-05 14:19
Reward40points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    610

Return to the list